Rep. Christopher Collins (R-NY), an early backer of President Trump, was charged with participating in an insider-trading scheme to sell shares of an Australian biotechnology company before the public disclosure of a failed drug trial. He intends to stand for re-election . . .
Want to read more? Please subscribe to The Crime Report!